文献速递美容整形

COVID-19疫情期间认证门诊手术机构择期整形手术安全恢复

The Safe Resumption of Elective Plastic Surgery in Accredited Ambulatory Surgery Facilities During the COVID-19 Pandemic.
PubMed 文献 · Aesthet Surg J · 2021-01-01

该前瞻性研究在6家认证门诊手术机构连续纳入368例择期美容整形手术患者,评估疫情期间恢复择期手术的安全性。结果显示352例(95.7%)完成COVID-19 PCR检测且均阴性,术后7例(1.9%)出现并发症,仅1例(0.3%)需住院,30天内无患者或医护人员出现COVID-19症状或检测阳性。结论认为经适当筛查和防护,择期美容整形手术可安全开展。

要点

  • 368例择期美容整形手术患者术前筛查均阴性,352例(95.7%)PCR检测阴性。
  • 术后并发症7例(1.9%),需就医3例(0.8%),需住院1例(0.3%)。
  • 术后30天内无患者或医护人员出现COVID-19症状或检测阳性。

核心结论

  • 经适当筛查和安全防护,择期美容整形手术对患者和医护人员安全,社区病毒传播加速风险极低。

研究设计与样本

  • 前瞻性研究,连续纳入6家认证门诊手术机构中接受择期整形手术并需全身麻醉的368例患者。

主要发现

  • 368例患者术前筛查均阴性,352例(95.7%)完成COVID-19 PCR检测且均阴性。
  • 术后7例(1.9%)出现并发症,3例(0.8%)需就医,1例(0.3%)需住院。
  • 术后30天内无患者或医护人员出现COVID-19症状或检测阳性。

临床怎么用

  • 在认证门诊手术机构中,通过术前筛查和防护措施可安全恢复择期美容整形手术。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: On March 11, 2020, the World Health Organization declared the novel Coronavirus-19 (COVID-19) a worldwide pandemic, resulting in an unprecedented shift in the Canadian healthcare system, where protection of an already overloaded system became a priority; all elective surgeries and non-essential activities were ceased. With the impact being less than predicted, on May 26, 2020, elective surgeries and non-essential activities were permitted to resume. OBJECTIVES: The authors sought to examine outcomes following elective aesthetic surgery and the impact on the Canadian healthcare system with the resumption of these services during the COVID-19 worldwide pandemic. METHODS: Data were collected in a prospective manner on consecutive patients who underwent elective plastic surgery procedures in 6 accredited ambulatory surgery facilities. Data included patient demographics, procedural characteristics, COVID-19 polymerase chain reaction (PCR) test status, airway management, and postoperative outcomes. RESULTS: A total of 368 patients underwent elective surgical procedures requiring a general anesthetic. All 368 patients who underwent surgery were negative on pre-visit screening. A COVID-19 PCR test was completed by 352 patients (95.7%) and all were negative. In the postoperative period, 7 patients (1.9%) had complications, 3 patients (0.8%) required a hospital visit, and 1 patient (0.3%) required hospital admission. No patients or healthcare providers developed COVID-19 symptoms or had a positive test for COVID-19 within 30 days of surgery. CONCLUSIONS: With appropriate screening and safety precautions, elective aesthetic plastic surgery can be performed in a manner that is safe for patients and healthcare providers and with a very low risk for accelerating virus transmission within the community.

来源:Aesthet Surg J,查看原文。版权归原作者所有。

引用

  1. Brown M, Eardley S, Ahmad J, et al. The Safe Resumption of Elective Plastic Surgery in Accredited Ambulatory Surgery Facilities During the COVID-19 Pandemic. Aesthet Surg J. 2021. PMID: 33367485. doi:10.1093/asj/sjaa311

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。